Literature DB >> 25680943

Differential expression of efflux pump genes of Mycobacterium tuberculosis in response to varied subinhibitory concentrations of antituberculosis agents.

Kushal Garima1, Rakesh Pathak1, Rashmi Tandon2, Nisha Rathor1, Rajesh Sinha1, Mridula Bose1, Mandira Varma-Basil3.   

Abstract

Several reports have elaborated on the role of efflux pumps in drug resistance in Mycobacterium tuberculosis by analysing the mRNA expression profiles. However, there is no uniformity in the subinhibitory concentrations of drugs chosen in these studies. Some investigators studied the expression of efflux pumps under a drug concentration of 1/2 minimum inhibitory concentration (MIC), while others used 1/3, 1/4 or 1/8MIC. The present study was planned to understand the effect of different concentrations of antituberculosis drugs on the expression of efflux pump genes. Log phase culture of the laboratory strain M. tuberculosis H37Rv was exposed to rifampicin (RIF), isoniazid (INH), streptomycin (SM) and ethambutol (EMB) at different drug concentrations (1/2MIC, 1/3MIC and 1/4MIC). The expression of 10 putative efflux pump genes was studied using quantitative Real Time-Polymerase Chain Reaction (qRT-PCR). We observed an optimal expression of efflux pumps at higher concentrations of INH; and at lower concentrations of RIF and EMB. However, in the presence of SM, a decreased expression of efflux genes with increasing concentrations of the drug was confounded by a significant reduction in Colony Forming Units (CFU).
Copyright © 2015 Elsevier Ltd. All rights reserved.

Entities:  

Keywords:  Antituberculosis agents; Efflux pumps; Mycobacterium tuberculosis

Mesh:

Substances:

Year:  2015        PMID: 25680943     DOI: 10.1016/j.tube.2015.01.005

Source DB:  PubMed          Journal:  Tuberculosis (Edinb)        ISSN: 1472-9792            Impact factor:   3.131


  15 in total

1.  The Putative Major Facilitator Superfamily (MFS) Protein Named Rv1877 in Mycobacterium tuberculosis Behaves as a Multidrug Efflux Pump.

Authors:  Anwesha Adhikary; Sarmistha Biswal; Anindya Sundar Ghosh
Journal:  Curr Microbiol       Date:  2022-09-20       Impact factor: 2.343

Review 2.  New Insights in to the Intrinsic and Acquired Drug Resistance Mechanisms in Mycobacteria.

Authors:  Mohammad J Nasiri; Mehri Haeili; Mona Ghazi; Hossein Goudarzi; Ali Pormohammad; Abbas A Imani Fooladi; Mohammad M Feizabadi
Journal:  Front Microbiol       Date:  2017-04-25       Impact factor: 5.640

3.  Interplay between Mutations and Efflux in Drug Resistant Clinical Isolates of Mycobacterium tuberculosis.

Authors:  Diana Machado; Tatiane S Coelho; João Perdigão; Catarina Pereira; Isabel Couto; Isabel Portugal; Raquel De Abreu Maschmann; Daniela F Ramos; Andrea von Groll; Maria L R Rossetti; Pedro A Silva; Miguel Viveiros
Journal:  Front Microbiol       Date:  2017-04-27       Impact factor: 5.640

4.  Phospholipid homeostasis, membrane tenacity and survival of Mtb in lipid rich conditions is determined by MmpL11 function.

Authors:  Ankur Bothra; Prabhakar Arumugam; Vipul Panchal; Dilip Menon; Sonali Srivastava; Deepthi Shankaran; Ananya Nandy; Neetika Jaisinghani; Archana Singh; Rajesh S Gokhale; Sheetal Gandotra; Vivek Rao
Journal:  Sci Rep       Date:  2018-05-29       Impact factor: 4.379

Review 5.  New Roads Leading to Old Destinations: Efflux Pumps as Targets to Reverse Multidrug Resistance in Bacteria.

Authors:  Gabriella Spengler; Annamária Kincses; Márió Gajdács; Leonard Amaral
Journal:  Molecules       Date:  2017-03-15       Impact factor: 4.411

6.  Potential impact of efflux pump genes in mediating rifampicin resistance in clinical isolates of Mycobacterium tuberculosis from India.

Authors:  Anshika Narang; Kushal Garima; Shraddha Porwal; Archana Bhandekar; Kamal Shrivastava; Astha Giri; Naresh Kumar Sharma; Mridula Bose; Mandira Varma-Basil
Journal:  PLoS One       Date:  2019-09-26       Impact factor: 3.240

7.  Dually Acting Nonclassical 1,4-Dihydropyridines Promote the Anti-Tuberculosis (Tb) Activities of Clofazimine.

Authors:  Fabian Lentz; Norbert Reiling; Gabriella Spengler; Annamária Kincses; Andrea Csonka; Joseph Molnár; Andreas Hilgeroth
Journal:  Molecules       Date:  2019-08-08       Impact factor: 4.411

8.  Discovery of Novel Enhancers of Isoniazid Toxicity in Mycobacterium tuberculosis.

Authors:  Fabian Lentz; Norbert Reiling; Ana Martins; Joseph Molnár; Andreas Hilgeroth
Journal:  Molecules       Date:  2018-04-04       Impact factor: 4.411

9.  A complete high-quality MinION nanopore assembly of an extensively drug-resistant Mycobacterium tuberculosis Beijing lineage strain identifies novel variation in repetitive PE/PPE gene regions.

Authors:  Arnold Bainomugisa; Tania Duarte; Evelyn Lavu; Sushil Pandey; Chris Coulter; Ben J Marais; Lachlan M Coin
Journal:  Microb Genom       Date:  2018-06-15

10.  Whole genome sequencing, analyses of drug resistance-conferring mutations, and correlation with transmission of Mycobacterium tuberculosis carrying katG-S315T in Hanoi, Vietnam.

Authors:  Nguyen Thi Le Hang; Minako Hijikata; Shinji Maeda; Pham Huu Thuong; Jun Ohashi; Hoang Van Huan; Nguyen Phuong Hoang; Akiko Miyabayashi; Vu Cao Cuong; Shintaro Seto; Nguyen Van Hung; Naoto Keicho
Journal:  Sci Rep       Date:  2019-10-25       Impact factor: 4.379

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.